Annual Total Long Term Liabilities
$304.80 M
+$52.39 M+20.76%
December 31, 2023
Summary
- As of February 7, 2025, MCRB annual total long term liabilities is $304.80 million, with the most recent change of +$52.39 million (+20.76%) on December 31, 2023.
- During the last 3 years, MCRB annual total long term liabilities has risen by +$183.02 million (+150.30%).
- MCRB annual total long term liabilities is now at all-time high.
Performance
MCRB Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$89.99 M
-$210.53 M-70.06%
September 30, 2024
Summary
- As of February 7, 2025, MCRB quarterly total long term liabilities is $89.99 million, with the most recent change of -$210.53 million (-70.06%) on September 30, 2024.
- Over the past year, MCRB quarterly long term liabilities has dropped by -$214.81 million (-70.48%).
- MCRB quarterly long term liabilities is now -70.58% below its all-time high of $305.88 million, reached on June 30, 2023.
Performance
MCRB Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
MCRB Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +20.8% | -70.5% |
| 3 y3 years | +150.3% | -64.3% |
| 5 y5 years | +141.0% | -64.3% |
MCRB Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +116.0% | -70.6% | at low |
| 5 y | 5-year | at high | +150.3% | -70.6% | at low |
| alltime | all time | at high | >+9999.0% | -70.6% | -100.0% |
Seres Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $89.99 M(-70.1%) |
| Jun 2024 | - | $300.52 M(-0.7%) |
| Mar 2024 | - | $302.52 M(-0.7%) |
| Dec 2023 | $304.80 M(+20.8%) | $304.80 M(+0.4%) |
| Sep 2023 | - | $303.60 M(-0.7%) |
| Jun 2023 | - | $305.88 M(+20.3%) |
| Mar 2023 | - | $254.25 M(+0.7%) |
| Dec 2022 | $252.41 M(+78.9%) | $252.41 M(+55.4%) |
| Sep 2022 | - | $162.46 M(+0.8%) |
| Jun 2022 | - | $161.10 M(+2.9%) |
| Mar 2022 | - | $156.57 M(+11.0%) |
| Dec 2021 | $141.09 M(+15.9%) | $141.09 M(+12.0%) |
| Sep 2021 | - | $125.96 M(+12.1%) |
| Jun 2021 | - | $112.42 M(-1.5%) |
| Mar 2021 | - | $114.13 M(-6.3%) |
| Dec 2020 | $121.78 M(-9.6%) | $121.78 M(-0.5%) |
| Sep 2020 | - | $122.38 M(+0.3%) |
| Jun 2020 | - | $122.00 M(-4.8%) |
| Mar 2020 | - | $128.15 M(-4.9%) |
| Dec 2019 | $134.77 M | $134.77 M(+18.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $114.13 M(-5.7%) |
| Jun 2019 | - | $120.99 M(-10.6%) |
| Mar 2019 | - | $135.31 M(+7.0%) |
| Dec 2018 | $126.48 M(+30.1%) | $126.48 M(+25.7%) |
| Sep 2018 | - | $100.60 M(-8.1%) |
| Jun 2018 | - | $109.44 M(-4.2%) |
| Mar 2018 | - | $114.25 M(+17.5%) |
| Dec 2017 | $97.20 M(-11.3%) | $97.20 M(-2.2%) |
| Sep 2017 | - | $99.34 M(-3.3%) |
| Jun 2017 | - | $102.75 M(-3.2%) |
| Mar 2017 | - | $106.15 M(-3.1%) |
| Dec 2016 | $109.56 M(>+9900.0%) | $109.56 M(-1.9%) |
| Sep 2016 | - | $111.64 M(+0.1%) |
| Jun 2016 | - | $111.49 M(+1.5%) |
| Mar 2016 | - | $109.82 M(>+9900.0%) |
| Dec 2015 | $586.00 K(-99.6%) | $586.00 K(>+9900.0%) |
| Sep 2015 | - | $0.00(-100.0%) |
| Jun 2015 | - | $727.00 K(-28.4%) |
| Mar 2015 | - | $1.02 M(-99.3%) |
| Dec 2014 | $138.96 M(+1040.4%) | $138.96 M |
| Dec 2013 | $12.19 M | - |
FAQ
- What is Seres Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Seres Therapeutics?
- What is Seres Therapeutics annual total long term liabilities year-on-year change?
- What is Seres Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Seres Therapeutics?
- What is Seres Therapeutics quarterly long term liabilities year-on-year change?
What is Seres Therapeutics annual total long term liabilities?
The current annual total long term liabilities of MCRB is $304.80 M
What is the all time high annual total long term liabilities for Seres Therapeutics?
Seres Therapeutics all-time high annual total long term liabilities is $304.80 M
What is Seres Therapeutics annual total long term liabilities year-on-year change?
Over the past year, MCRB annual total long term liabilities has changed by +$52.39 M (+20.76%)
What is Seres Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of MCRB is $89.99 M
What is the all time high quarterly long term liabilities for Seres Therapeutics?
Seres Therapeutics all-time high quarterly total long term liabilities is $305.88 M
What is Seres Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, MCRB quarterly total long term liabilities has changed by -$214.81 M (-70.48%)